Morgan Stanley Rallybio Corp Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Rallybio Corp stock. As of the latest transaction made, Morgan Stanley holds 4,640 shares of RLYB stock, worth $2,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,640

Previous 36,484 87.28%

Holding current value

$2,969

Previous $12,000 83.33%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.32 - $0.63 $10,190 - $20,061	-31,844 Reduced 87.28%	4,640 $2,000
Q3 2024 May 14, 2025	SELL	$1.09 - $1.45 $20,275 - $26,971	-18,601 Reduced 33.77%	36,484 $42,000
Q3 2024 Nov 14, 2024	SELL	$1.09 - $1.45 $20,275 - $26,971	-18,601 Reduced 33.77%	36,484 $42,000
Q2 2024 May 14, 2025	BUY	$1.34 - $2.98 $24,925 - $55,430	18,601 Added 50.98%	55,085 $73,000
Q2 2024 Oct 17, 2024	SELL	$1.34 - $2.98 $28,537 - $63,465	-21,297 Reduced 27.88%	55,085 $73,000
Q2 2024 Aug 14, 2024	SELL	$1.34 - $2.98 $28,537 - $63,465	-21,297 Reduced 27.88%	55,085 $73,000
Q1 2024 Oct 17, 2024	BUY	$1.25 - $2.4 $26,621 - $51,112	21,297 Added 38.66%	76,382 $141,000
Q1 2024 Aug 16, 2024	SELL	$1.25 - $2.4 $28,421 - $54,568	-22,737 Reduced 22.94%	76,382 $141,000
Q1 2024 May 15, 2024	SELL	$1.25 - $2.4 $28,421 - $54,568	-22,737 Reduced 22.94%	76,382 $141,000
Q4 2023 Aug 16, 2024	BUY	$1.91 - $4.39 $84,104 - $193,309	44,034 Added 79.94%	99,119 $236,000
Q4 2023 Feb 13, 2024	BUY	$1.91 - $4.39 $159,183 - $365,871	83,342 Added 528.25%	99,119 $236,000
Q3 2023 Nov 15, 2023	SELL	$3.37 - $6.16 $20,688 - $37,816	-6,139 Reduced 28.01%	15,777 $53,000
Q2 2023 Aug 14, 2023	BUY	$4.31 - $8.89 $54,228 - $111,853	12,582 Added 134.8%	21,916 $124,000
Q1 2023 May 15, 2023	BUY	$4.37 - $8.75 $33,701 - $67,480	7,712 Added 475.46%	9,334 $53,000
Q4 2022 Feb 14, 2023	SELL	$4.67 - $14.86 $22,663 - $72,115	-4,853 Reduced 74.95%	1,622 $10,000
Q3 2022 Nov 14, 2022	SELL	$7.54 - $14.56 $12,599 - $24,329	-1,671 Reduced 20.51%	6,475 $94,000
Q2 2022 Oct 27, 2022	SELL	$6.26 - $13.65 $10,460 - $22,809	-1,671 Reduced 17.02%	8,146 $61,000
Q2 2022 Aug 15, 2022	SELL	$6.26 - $13.65 $10,460 - $22,809	-1,671 Reduced 17.02%	8,146 $61,000
Q1 2022 Oct 27, 2022	BUY	$6.91 - $15.04 $11,546 - $25,131	1,671 Added 20.51%	9,817 $69,000
Q1 2022 May 13, 2022	BUY	$6.91 - $15.04 $13,267 - $28,876	1,920 Added 24.31%	9,817 $69,000
Q4 2021 Feb 14, 2022	BUY	$9.3 - $19.91 $53,428 - $114,382	5,745 Added 266.96%	7,897 $76,000
Q3 2021 Nov 15, 2021	BUY	$10.83 - $23.4 $23,306 - $50,356	2,152 New	2,152 $38,000

Others Institutions Holding RLYB

# of Institutions

Shares Held

28.9M

Call Options Held

Put Options Held

View Full List

About Rallybio Corp

Ticker RLYB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,132,000
Market Cap $20.6M
Description
Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...

More about RLYB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account